Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-014027
Filing Date
2025-02-14
Accepted
2025-02-14 16:01:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9750
  Complete submission text file 0001104659-25-014027.txt   11400
Mailing Address 30 STAR ISLAND DRIVE MIAMI BEACH FL 33139
Business Address 30 STAR ISLAND DRIVE MIAMI BEACH FL 33139 212-808-7729
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92951 | Film No.: 25628069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)